We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Chugai Pharmaceutical: To Recall Leukemia Drug In Japan (Japan)

This article was originally published in PharmAsia News

06 Aug 2007

News

Executive Summary

Chugai Pharmaceutical Co. has started recalling a leukemia drug, Vesanoid, in Japan as a specified batch of the drug from its parent Roche Holding AG contained material that wasn't approved by the Japanese government. The company said capsules of the drug in this particular batch contained bovine-derived material sourced from Canada. Use of the material in question is approved overseas, but it requires special approval from the government in Japan. Roche had thought that the use of the material had been approved by the Japanese government and exported the batch to Japan. Chugai is recalling 1,998 bottles of Vesanoid Capsule shipped to 740 medical institutions between Jan. 5 and June 18 this year. (Click here for more - May Require Paid Subscription